DK136091D0 - 1h-imidazo/4,5-c/quinolinderivat - Google Patents

1h-imidazo/4,5-c/quinolinderivat

Info

Publication number: DK136091D0
Authority: DK; Denmark
Prior art keywords: carbon atoms; imidazo; group; quinoline derivative; alkyl
Prior art date: 1983-11-18

Application number

DK911360A

Other languages

English (en)

Other versions

DK164451C (da

DK136091A (da

DK164451B (da

Inventor

John F Gerster

Original Assignee

Riker Laboratories Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-11-18

Filing date

1991-07-16

Publication date

1991-07-16

1991-07-16 Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc

1991-07-16 Publication of DK136091A publication Critical patent/DK136091A/da

1991-07-16 Publication of DK136091D0 publication Critical patent/DK136091D0/da

1992-06-29 Publication of DK164451B publication Critical patent/DK164451B/da

1992-11-09 Application granted granted Critical

1992-11-09 Publication of DK164451C publication Critical patent/DK164451C/da

Links

125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 5
125000000217 alkyl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
ITIRVXDSMXFTPW-UHFFFAOYSA-N 1H-imidazo[4,5-c]quinoline Chemical class C1=CC=CC2=C(NC=N3)C3=CN=C21 ITIRVXDSMXFTPW-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Physical Water Treatments (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Macromonomer-Based Addition Polymer (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Alarm Systems (AREA)
Quinoline Compounds (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Lubricants (AREA)
Luminescent Compositions (AREA)

DK136091A 1983-11-18 1991-07-16 3-aminoquinolinderivat DK164451C (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US55315883A	1983-11-18	1983-11-18
US55315783A	1983-11-18	1983-11-18
US55315783		1983-11-18
US55315883		1983-11-18

Publications (4)

Publication Number	Publication Date
DK136091A DK136091A (da)	1991-07-16
DK136091D0 true DK136091D0 (da)	1991-07-16
DK164451B DK164451B (da)	1992-06-29
DK164451C DK164451C (da)	1992-11-09

Family

ID=27070262

Family Applications (6)

Application Number	Title	Priority Date	Filing Date
DK542684A DK164280C (da)	1983-11-18	1984-11-15	1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK136191A DK164452C (da)	1983-11-18	1991-07-16	3-nitroquinolinderivat
DK135791A DK169179B1 (da)	1983-11-18	1991-07-16	1H-imidazo[4,5-c]quinolin-4-amin, farmaceutisk præparat indeholdende en sådan forbindelse og fremga ngsmåde til fremstilling af en sådan forbindelse
DK135991A DK165921C (da)	1983-11-18	1991-07-16	1h-imidazooe4,5-caaquinolin-5-oxyforbindelser
DK136091A DK164451C (da)	1983-11-18	1991-07-16	3-aminoquinolinderivat
DK135891A DK164455C (da)	1983-11-18	1991-07-16	1h-imidazooe4,5-caaquinolin-4-chlorforbindelser

Family Applications Before (4)

Application Number	Title	Priority Date	Filing Date
DK542684A DK164280C (da)	1983-11-18	1984-11-15	1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK136191A DK164452C (da)	1983-11-18	1991-07-16	3-nitroquinolinderivat
DK135791A DK169179B1 (da)	1983-11-18	1991-07-16	1H-imidazo[4,5-c]quinolin-4-amin, farmaceutisk præparat indeholdende en sådan forbindelse og fremga ngsmåde til fremstilling af en sådan forbindelse
DK135991A DK165921C (da)	1983-11-18	1991-07-16	1h-imidazooe4,5-caaquinolin-5-oxyforbindelser

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK135891A DK164455C (da)	1983-11-18	1991-07-16	1h-imidazooe4,5-caaquinolin-4-chlorforbindelser

Country Status (15)

Country	Link
EP (2)	EP0310950B1 (da)
JP (1)	JPS60123488A (da)
KR (1)	KR900005657B1 (da)
AT (2)	ATE49763T1 (da)
AU (2)	AU581190B2 (da)
CA (1)	CA1271477A (da)
DE (3)	DE3486043T2 (da)
DK (6)	DK164280C (da)
ES (1)	ES8603477A1 (da)
IE (1)	IE57874B1 (da)
IL (2)	IL84537A (da)
NL (2)	NL980043I1 (da)
NO (7)	NO163819C (da)
NZ (1)	NZ210228A (da)
PH (1)	PH22338A (da)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1306260C (en)	1985-10-18	1992-08-11	Shionogi & Co., Ltd.	Condensed imidazopyridine derivatives
US4942168A (en) *	1987-07-13	1990-07-17	Hoechst-Roussel Pharmaceuticals Inc.	Hydroxyquinoline amines, and method of enhancing memory in mammals
CA1335996C (en) *	1988-02-16	1995-06-20	Susumu Takada	2-substituted carbonylimidazo¬4,5-c\|quinolines
US5019574A (en) *	1988-09-30	1991-05-28	Chugai Seiyaku Kabushiki Kaisha	3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function
DK0385630T3 (da) *	1989-02-27	1997-05-12	Riker Laboratories Inc	1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler
CA2011504C (en) *	1989-03-07	1998-06-02	Kenji Ohmori	Imidazoquinolone derivatives
US4929624A (en) *	1989-03-23	1990-05-29	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
JP2988692B2 (ja) *	1989-07-18	1999-12-13	協和醗酵工業株式会社	イミダゾキノロン誘導体
US4988815A (en) *	1989-10-26	1991-01-29	Riker Laboratories, Inc.	3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
FR2654021B1 (fr) *	1989-11-07	1992-02-28	Simond Jacques	Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
GB8928281D0 (en) *	1989-12-14	1990-02-21	Smith Kline French Lab	Compounds
CA2043715C (en) *	1990-06-01	1997-01-07	Fumio Suzuki	Imidazonaphthyridine derivatives
EP0872478B1 (en) *	1991-03-01	2002-12-18	Minnesota Mining And Manufacturing Company	Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5266575A (en) *	1991-11-06	1993-11-30	Minnesota Mining And Manufacturing Company	2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) *	1992-04-16	1996-11-14	Minnesota Mining & Mfg	Immunogen/vaccine adjuvant composition
US5395937A (en) *	1993-01-29	1995-03-07	Minnesota Mining And Manufacturing Company	Process for preparing quinoline amines
US5693811A (en) *	1996-06-21	1997-12-02	Minnesota Mining And Manufacturing Company	Process for preparing tetrahdroimidazoquinolinamines
JP4101302B2 (ja) *	1997-01-09	2008-06-18	テルモ株式会社	新規アミド誘導体および合成中間体
JPH10298181A (ja) *	1997-04-25	1998-11-10	Sumitomo Pharmaceut Co Ltd	タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤
JP2000119271A (ja) *	1998-08-12	2000-04-25	Hokuriku Seiyaku Co Ltd	１ｈ―イミダゾピリジン誘導体
UA74852C2 (en) *	2000-12-08	2006-02-15	3M Innovative Properties Co	Urea-substituted imidazoquinoline ethers
WO2003035626A2 (en) *	2001-10-23	2003-05-01	Applied Research Systems Ars Holding N.V.	Azole derivatives and pharmaceutical compositions containing them
GB0211649D0 (en)	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
DK1543002T3 (da)	2002-07-23	2006-12-27	Teva Gyogyszergyar Zartkoeruee	Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter
PL374866A1 (en)	2002-07-26	2005-11-14	Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag	Preparation of 1h-imidazo [4,5-c] quinolin-4-amines via novel 1h-imidazo [4,5-c] quinolin-4-cyano and 1h-imidazo [4,5-c] quinolin-4-carboxamide intermediates
MXPA06001669A (es)	2003-08-12	2006-04-28	3M Innovative Properties Co	Compuestos que contienen imidazo-oxima sustituidos.
NZ545412A (en) *	2003-08-27	2008-12-24	Coley Pharm Group Inc	Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2007504269A (ja)	2003-09-05	2007-03-01	スリーエムイノベイティブプロパティズカンパニー	Ｃｄ５＋ｂ細胞リンパ腫の治療方法
WO2005033049A2 (en)	2003-10-01	2005-04-14	Taro Pharmaceuticals U.S.A., Inc.	METHOD OF PREPARING 4-AMINO-1H-IMIDAZO(4,5-c)QUINOLINES AND ACID ADDITION SALTS THEREOF
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
EP1673087B1 (en) *	2003-10-03	2015-05-13	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
ITMI20032121A1 (it) *	2003-11-04	2005-05-05	Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm	Procedimento per la preparazione di imiquimod e suoi intermedi
WO2005048933A2 (en)	2003-11-14	2005-06-02	3M Innovative Properties Company	Oxime substituted imidazo ring compounds
CN1906192A (zh)	2003-11-14	2007-01-31	3M创新有限公司	羟胺取代的咪唑环化合物
AU2004293078B2 (en)	2003-11-25	2012-01-19	3M Innovative Properties Company	Substituted imidazo ring systems and methods
JP2007517035A (ja)	2003-12-29	2007-06-28	スリーエムイノベイティブプロパティズカンパニー	アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en)	2003-12-30	2006-09-13	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
US8697873B2 (en)	2004-03-24	2014-04-15	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en)	2004-06-15	2011-09-13	3M Innovative Properties Company	Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en)	2004-06-18	2011-03-29	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006038923A2 (en)	2004-06-18	2006-04-13	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
WO2006009826A1 (en)	2004-06-18	2006-01-26	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
JP5313502B2 (ja)	2004-12-30	2013-10-09	スリーエムイノベイティブプロパティズカンパニー	置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2592904C (en)	2004-12-30	2015-04-07	3M Innovative Properties Company	Chiral fused [1,2]imidazo[4,5-c] ring compounds
JP2008530022A (ja)	2005-02-04	2008-08-07	コーリーファーマシューティカルグループ，インコーポレイテッド	免疫反応調節物質を含む水性ゲル処方物
EP1846405A2 (en)	2005-02-11	2007-10-24	3M Innovative Properties Company	Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
CA2602683A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
JP2009504803A (ja)	2005-08-22	2009-02-05	ザリージェンツオブザユニバーシティオブカリフォルニア	Ｔｌｒアゴニスト
EP2029597A4 (en)	2006-05-31	2011-11-23	Univ California	purine analogs
WO2008008432A2 (en)	2006-07-12	2008-01-17	Coley Pharmaceutical Group, Inc.	Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
ES2456964T3 (es)	2007-02-07	2014-04-24	The Regents Of The University Of California	Conjugados de agonistas de TLR sintéticos y usos de los mismos
EP2009002A1 (en) *	2007-06-21	2008-12-31	Institut National De La Sante Et De La Recherche Medicale (Inserm)	New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
WO2010088924A1 (en)	2009-02-06	2010-08-12	Telormedix Sa	Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
WO2010093436A2 (en)	2009-02-11	2010-08-19	Carson Dennis A	Toll-like receptor modulators and treatment of diseases
LT2606047T (lt)	2010-08-17	2017-04-10	3M Innovative Properties Company	Imuninio atsako modifikatoriaus junginio lipidizuotos kompozicijos, sudėtys ir būdai
US8728486B2 (en)	2011-05-18	2014-05-20	University Of Kansas	Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
CA2850932A1 (en) *	2011-10-04	2013-04-11	Janus Biotherapeutics, Inc.	Novel imidazole quinoline-based immune system modulators
CA3217159A1 (en) *	2013-02-01	2014-08-07	Wellstat Therapeutics Corporation	Substituted quinazolin-4-amine compounds and pharmaceutical compositions thereof having anti-inflammatory, antifungal, antiparasitic and anticancer activity
CA2902833A1 (en)	2013-03-15	2014-09-18	Syngenta Participations Ag	Microbicidally active imidazopyridine derivatives
ES2538880B1 (es) *	2013-12-24	2016-09-08	Laboratorios Viñas S.A.	Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
EP3092255A4 (en)	2014-01-10	2017-09-20	Birdie Biopharmaceuticals Inc.	Compounds and compositions for treating egfr expressing tumors
CA2954446A1 (en)	2014-07-09	2016-01-14	Shanghai Birdie Biotech, Inc.	Anti-pd-l1 combinations for treating tumors
CN108137586B (zh) *	2015-09-14	2021-04-13	辉瑞大药厂	作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物
CN115252792A (zh)	2016-01-07	2022-11-01	博笛生物科技有限公司	用于治疗肿瘤的抗-egfr组合
CN115554406A (zh)	2016-01-07	2023-01-03	博笛生物科技有限公司	用于治疗肿瘤的抗-cd20组合
US10533007B2 (en)	2016-04-19	2020-01-14	Innate Tumor Immunity, Inc.	NLRP3 modulators
BR112018071347A2 (pt)	2016-04-19	2019-02-05	Innate Tumor Immunity Inc	moduladores de nlrp3
US11697851B2 (en)	2016-05-24	2023-07-11	The Regents Of The University Of California	Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI674261B (zh)	2017-02-17	2019-10-11	美商英能腫瘤免疫股份有限公司	Nlrp3 調節劑
CN118515666A (zh)	2017-04-27	2024-08-20	博笛生物科技有限公司	2-氨基-喹啉衍生物
KR20200019226A (ko)	2017-06-23	2020-02-21	버디 바이오파마슈티칼즈, 인크.	약학 조성물
FR3113287B1 (fr)	2020-08-07	2023-06-23	Phv Pharma	Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique
CN116528875A (zh) *	2020-12-09	2023-08-01	维尔斯达医疗公司	具有抗炎、抗真菌、抗寄生虫和抗癌活性的咪唑并喹啉化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3700674A (en) *	1969-04-30	1972-10-24	American Cyanamid Co	4-alkylamino-3-nitroquinolines
ZA832938B (en) *	1982-05-03	1984-12-24	Lilly Co Eli	2-phenylimidazo(4,5-c)pyridines

1984
- 1984-11-13 CA CA000467706A patent/CA1271477A/en not_active Expired - Lifetime
- 1984-11-14 AU AU35402/84A patent/AU581190B2/en not_active Expired
- 1984-11-15 ES ES537677A patent/ES8603477A1/es not_active Expired
- 1984-11-15 NO NO844565A patent/NO163819C/no not_active IP Right Cessation
- 1984-11-15 DK DK542684A patent/DK164280C/da not_active IP Right Cessation
- 1984-11-16 AT AT84307974T patent/ATE49763T1/de active
- 1984-11-16 NZ NZ210228A patent/NZ210228A/xx unknown
- 1984-11-16 IE IE2952/84A patent/IE57874B1/en not_active IP Right Cessation
- 1984-11-16 EP EP88116137A patent/EP0310950B1/en not_active Expired - Lifetime
- 1984-11-16 EP EP84307974A patent/EP0145340B1/en not_active Expired - Lifetime
- 1984-11-16 DE DE8888116137T patent/DE3486043T2/de not_active Expired - Lifetime
- 1984-11-16 PH PH31451A patent/PH22338A/en unknown
- 1984-11-16 IL IL84537A patent/IL84537A/xx not_active IP Right Cessation
- 1984-11-16 AT AT88116137T patent/ATE84525T1/de not_active IP Right Cessation
- 1984-11-16 DE DE1999175027 patent/DE19975027I2/de active Active
- 1984-11-16 DE DE8484307974T patent/DE3481124D1/de not_active Expired - Lifetime
- 1984-11-17 JP JP59243142A patent/JPS60123488A/ja active Granted
- 1984-11-17 KR KR1019840007224A patent/KR900005657B1/ko not_active Expired
1987
- 1987-11-19 IL IL84537A patent/IL84537A0/xx unknown
1989
- 1989-02-14 AU AU29911/89A patent/AU611997B2/en not_active Expired
- 1989-02-27 NO NO890825A patent/NO169437C/no not_active IP Right Cessation
- 1989-02-27 NO NO890822A patent/NO165145C/no not_active IP Right Cessation
- 1989-02-27 NO NO890824A patent/NO165147C/no not_active IP Right Cessation
- 1989-02-27 NO NO890823A patent/NO165146C/no not_active IP Right Cessation
- 1989-02-27 NO NO890826A patent/NO168705C/no not_active IP Right Cessation
1991
- 1991-07-16 DK DK136191A patent/DK164452C/da not_active IP Right Cessation
- 1991-07-16 DK DK135791A patent/DK169179B1/da not_active IP Right Cessation
- 1991-07-16 DK DK135991A patent/DK165921C/da not_active IP Right Cessation
- 1991-07-16 DK DK136091A patent/DK164451C/da not_active IP Right Cessation
- 1991-07-16 DK DK135891A patent/DK164455C/da not_active IP Right Cessation
1998
- 1998-12-14 NL NL980043C patent/NL980043I1/nl unknown
- 1998-12-14 NL NL980041C patent/NL980041I2/nl unknown
1999
- 1999-07-08 NO NO1999015C patent/NO1999015I1/no unknown

Also Published As

Publication number	Publication date
NO890826D0 (no)	1989-02-27
NO890825L (no)	1985-05-20
NZ210228A (en)	1989-01-27
NO890826L (no)	1985-05-20
EP0145340B1 (en)	1990-01-24
IL84537A0 (en)	1988-04-29
NO168705B (no)	1991-12-16
DK135991D0 (da)	1991-07-16
DK135991A (da)	1991-07-16
CA1271477A (en)	1990-07-10
ATE84525T1 (de)	1993-01-15
NO169437B (no)	1992-03-16
EP0145340A3 (en)	1986-06-11
JPH0586391B2 (da)	1993-12-10
NO165146B (no)	1990-09-24
NO890822L (no)	1985-05-20
DK164451C (da)	1992-11-09
DK165921B (da)	1993-02-08
DK135791A (da)	1991-07-16
NO165145C (no)	1991-01-02
DK164452B (da)	1992-06-29
DK136091A (da)	1991-07-16
IE57874B1 (en)	1993-05-05
DK164280B (da)	1992-06-01
DK169179B1 (da)	1994-09-05
NL980041I1 (nl)	1999-02-01
NO163819B (no)	1990-04-17
PH22338A (en)	1988-08-12
NO1999015I1 (no)	1999-07-08
NO168705C (no)	1992-03-25
AU581190B2 (en)	1989-02-16
NO890824D0 (no)	1989-02-27
DK542684D0 (da)	1984-11-15
NO890825D0 (no)	1989-02-27
DK164455B (da)	1992-06-29
ES537677A0 (es)	1985-12-16
AU3540284A (en)	1985-05-23
EP0145340A2 (en)	1985-06-19
DK136191A (da)	1991-07-16
NL980043I1 (nl)	1999-02-01
DE3486043D1 (de)	1993-02-25
AU611997B2 (en)	1991-06-27
DK135891D0 (da)	1991-07-16
DK165921C (da)	1993-06-28
KR900005657B1 (ko)	1990-08-03
ATE49763T1 (de)	1990-02-15
DK164452C (da)	1992-11-09
AU2991189A (en)	1989-06-15
KR850003890A (ko)	1985-06-29
JPS60123488A (ja)	1985-07-02
NO169437C (no)	1992-06-24
DK135891A (da)	1991-07-16
NO165147C (no)	1991-01-02
DK135791D0 (da)	1991-07-16
ES8603477A1 (es)	1985-12-16
IE842952L (en)	1985-05-18
DK164455C (da)	1992-11-16
DE19975027I2 (de)	2000-09-21
NO890822D0 (no)	1989-02-27
EP0310950B1 (en)	1993-01-13
NO163819C (no)	1990-08-01
NO165145B (no)	1990-09-24
EP0310950A1 (en)	1989-04-12
NO165147B (no)	1990-09-24
NO890823D0 (no)	1989-02-27
DK136191D0 (da)	1991-07-16
NO890823L (no)	1985-05-20
NO844565L (no)	1985-05-20
DE3486043T2 (de)	1993-06-03
NO890824L (no)	1985-05-20
IL84537A (en)	1990-12-23
NO165146C (no)	1991-01-02
DK164451B (da)	1992-06-29
DK542684A (da)	1985-05-19
DE3481124D1 (de)	1990-03-01
DK164280C (da)	1992-11-30
NL980041I2 (nl)	1999-07-01

Legal Events

Date	Code	Title	Description
2004-12-06	PUP	Patent expired